<DOC>
	<DOC>NCT00620568</DOC>
	<brief_summary>This is a randomized, inpatient, ascending multiple dose study to assess safety and tolerability of SLV-313 SR tablets administered orally to subjects with schizophrenia and schizoaffective disorder.</brief_summary>
	<brief_title>Study Evaluating Multiple Ascending Dose in Schizophrenia Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Men, aged 1850 years old Women, aged 1850 years old Nonlactating women, aged 1850 years old Nonpregnant women, aged 1850 years old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Schizophrenia</keyword>
</DOC>